mRNA Coronavirus Disease 2019 Vaccine-Associated Myopericarditis in Adolescents: A Survey Study
Document Type
Journal Article
Publication Date
4-1-2022
Journal
The Journal of pediatrics
Volume
243
DOI
10.1016/j.jpeds.2021.12.025
Keywords
mRNA COVID-19 vaccine-associated myopericarditis; outcomes; survey; variability
Abstract
In this survey study of institutions across the US, marked variability in evaluation, treatment, and follow-up of adolescents 12 through 18 years of age with mRNA coronavirus disease 2019 (COVID-19) vaccine-associated myopericarditis was noted. Only one adolescent with life-threatening complications was reported, with no deaths at any of the participating institutions.
APA Citation
Kohli, Utkarsh; Desai, Lavina; Chowdhury, Devyani; Harahsheh, Ashraf S.; Yonts, Alexandra B.; Ansong, Annette; Sabati, Arash; Nguyen, Hoang H.; Hussain, Tarique; Khan, Danyal; Parra, David A.; Su, Jennifer A.; Patel, Jyoti K.; Ronai, Christina; Bohun, Monique; Freij, Bishara J.; O'Connor, Matthew J.; Rosanno, Joseph W.; Gupta, Aamisha; Salavitabar, Arash; Dorfman, Adam L.; Hansen, Jesse; Frosch, Olivia; Profita, Elizabeth L.; Maskatia, Shiraz; Thacker, Deepika; Shrivastava, Shubhika; Harris, Tyler H.; Feingold, Brian; Berger, Stuart; Campbell, Michael; and Idriss, Salim F., "mRNA Coronavirus Disease 2019 Vaccine-Associated Myopericarditis in Adolescents: A Survey Study" (2022). GW Authored Works. Paper 873.
https://hsrc.himmelfarb.gwu.edu/gwhpubs/873
Department
Pediatrics

- Citations
- Citation Indexes: 9
- Patent Family Citations: 1
- Policy Citations: 5
- Usage
- Abstract Views: 28
- Downloads: 11
- Captures
- Readers: 47
- Mentions
- News Mentions: 2